• Friday July 10,2020

abarelix

The medicine Abarelix is ​​a cytostatic. It is used under the trade name Plenaxis® for the treatment of advanced or already metastatic hormone-dependent prostate cancer, where other therapies no longer help. Abarelix was approved in Germany in 2008.

What is Abarelix?

Abarelix is ​​being marketed under the trade name Plenaxis® for the treatment of advanced or already metastatic hormone-dependent prostate cancer, where other therapies are no longer helpful.

Abarelix belongs to the group of gonadotropin releasing hormone antagonists (GnRH antagonists) and is a synthetic decapeptide. It is an alternative to surgical castration or therapy with GnRH analogues. Unlike GnRH analogues, Abarelix does not cause a - albeit short-term - increase in the hormone testosterone.

Such an increase can lead to an exacerbation of the symptoms - for example, to symptomatic bone metastases with spinal canal compression. On the other hand, when Abarelix is ​​administered, there is an immediate, rapid and reliable decrease in the serum testosterone concentration to less than 0.2 ng / ml.

The drug is available as a powder as well as a solvent for preparing a suspension for injection.

Currently, long-term experience with Abarelix therapy is limited. Above all, even more exact results are missing regarding allergic reactions of the immediate type and to cardiac side effects.

Pharmacological action

If treated with Abarelix, the drug is injected intramuscularly. Abarelix acts as a competitive receptor antagonist in competition with GnRH for the relevant receptors for testosterone production. The drug blocks the responsible receptors. The testosterone production then expires immediately.

Since this works so well, without there being a first brief increase in the testosterone level, the combination with anti-androgens is unnecessary. Even after the first injection, testosterone levels drop to castration levels within a few days - up to one week - in around 70% of patients. As a result of a second injection on the 15th day of therapy with Abarelix, the desired target value is found in almost all patients. Compared to other medicines, Abarelix not only works intensively, but also significantly faster.

As with surgical castration, drug therapy with Abarelix can lead to: impotence, hot flashes, weight gain, and weakness due to the greatly reduced levels of testosterone.

Medical application & use

For advanced and already metastatic prostate cancer, Abarelix has a new type of drug at hand. The drug is especially recommended when other forms of therapy promise no more success.

Abarelix dramatically reduces testosterone levels in conjunction with rapid and ongoing control of the prostate tumor. It lowers the PSA level and reduces the volume of the prostate. Unlike conventional GnRH agonists, the GnRH Antigonist Abarelix does not initially lead to a short-term increase in testosterone levels.

The agent initiates the desired effect immediately after the first intramuscular injection. Hormone-sensitive prostate cancer respond very well to medication with Abarelix. The medicine is an excellent supplement or even an alternative to radiation or surgery for advanced carcinoma of the prostate.

Attention should be paid to the patient for at least 30 minutes following administration of the injection, as Abarelix may cause anaphylactoid reaction in just under 4% of those treated. Immediate treatment for a potentially life-threatening allergic reaction must be guaranteed.

In the preliminary discussion with the patient for the treatment with Abarelix it should absolutely be pointed out that after termination of the treatment with Abarelix the effect is reversible. After drug reduction even a rapid normalization of testosterone levels is to be expected because Abarelix does not alter the receptors. Concomitants such as hot flashes can be replaced quickly.

If necessary, a later therapy with Abarelix can be started later.

Risks & Side Effects

Within 30 minutes of Abarelix injection, very rare cases of severe systemic allergic reaction of the immediate type may occur. The symptoms are itching, urticaria, hypotension and possibly syncope.

Other potential side effects include disorders of the gastrointestinal tract and more frequent respiratory infections.

Abarelix is ​​contraindicated in the heart's long QT syndrome as well as kidney and liver dysfunction. Like all GnRH antagonists, Abarelix should not be prescribed in the case of surgical castration.

Interesting Articles

pea

pea

Peas are among the most popular legumes and are processed either fresh or dried. Sugar peas can be eaten raw as the only legume. Green peas are mainly deep-frozen or canned, with frozen peas becoming more popular as they still contain all the vitamins. You should know that about the pea Peas are considered very healthy

Substantia spongiosa

Substantia spongiosa

The substantia spongiosa is the internal, bony network of bone substance. It mainly determines the carrying capacity of the bones. In osteoporosis, cancellous bone is increasingly broken down and the bone loses its bearing capacity. What is the Substantia spongiosa? The human bone tissue in its macroscopic form is also called substantia spongiosa

boxwood

boxwood

The ordinary boxwood is usually referred to simply as boxwood and belongs to the genus of the same name. This evergreen tree is primarily used as an ornamental wood, but is also occasionally still found in the wild. Occurrence & cultivation of the boxwood The boxwood is characterized by a dense and widely branched foliage, which is why it can be used not only as a shrub, but also as a whole hedge

Single photon emission computed tomography

Single photon emission computed tomography

Single Photon Emission Computed Tomography (SPECT) is part of the nuclear medicine examination spectrum. Their task is to assess the metabolism and thus the function in different organ systems. This is made possible by a radiopharmaceutical administered to the patient, the distribution of which in the body is visualized with the help of gamma cameras in the form of sectional images

Giardiasis (Lambliasis)

Giardiasis (Lambliasis)

Giardiasis refers to an infection of the intestine, which is caused by parasites. The disease is more common in childhood and can be treated well with antibiotics. Worldwide, about 200 million new infections occur annually, giardiasis occurs mainly in tropical countries. What is a Giardiasis? Giardiasis is usually a harmless disease

Nasal septum

Nasal septum

The nasal septum is median and separates the inside of the nose into left and right main nasal cavities. Different diseases can affect the function of the nasal septum, with the septum deviation (curvature of the nasal septum) is one of the most common disorders. What is the nasal septum? The nasal septum (nasal septum or nasal septum) is the median (central) continuous wall between the right and left nasal cavities (cavum nasi)